AAOS 2015: MM-II liposome intraarticular injection vs hyaluronic acid for knee OA .
Safety and Efficacy of Liposome Intraarticular Injection in Moderate Knee Osteoarthritis: A RCT
40 patients with moderate knee osteoarthritis and with clinical symptoms of pain were randomized to receive either MM-II injection, a phosphatidylcholine liposome construct, or a hyaluronic acid injection. The purpose was to compare the safety and efficacy of these two treatments. Outcomes of interest included VAS pain, WOMAC scores, knee range of motion, overall patient satisfaction, and complications. With possible efficacy in pain relief and reducing the need for acetaminophen, additional studies are needed investigating the use of MM-II injection in knee osteoarthritis.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
